Resolution of hypertensive encephalopathy and scleroderma renal crisis with an angiotensin receptor blocker

Pam R. Rajendran, Jerry A. Molitor

Research output: Contribution to journalArticle

5 Scopus citations


The use of an angiotensin II type-1 receptor blocker for scleroderma renal crisis is controversial. We describe a 46-year-old woman presenting with a seizure secondary to hypertensive encephalopathy as the initial manifestation of scleroderma renal crisis. She had complete resolution of end organ damage with use of an angiotensin II type-1 receptor blocker. There may be a role for angiotensin II type-1 receptor blockers in the setting of scleroderma renal crisis with central nervous system involvement.

Original languageEnglish (US)
Pages (from-to)205-208
Number of pages4
JournalJournal of Clinical Rheumatology
Issue number4
StatePublished - Aug 1 2005



  • ACE inhibitors
  • Hypertensive encephalopathy
  • Scleroderma

Cite this